{"title":"Association between partial smoking ban legislation and acute coronary syndrome: A nationwide analysis.","authors":"Michikazu Nakai, Yoshitaka Iwanaga, Hisayoshi Fujiwara","doi":"10.1016/j.jjcc.2025.06.023","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Tobacco smoking is a major risk factor for acute coronary syndrome (ACS) and acute myocardial infarction (AMI). While comprehensive smoking bans reduce cardiovascular events, the effectiveness of partial smoking ban legislation (pSBL) remains uncertain. In April 2020, Japan implemented a pSBL targeting certain public facilities. This study aimed to evaluate the impact of this nationwide pSBL on ACS and AMI hospitalizations.</p><p><strong>Methods: </strong>We conducted an interrupted time series analysis using data from the JROAD-DPC database, covering hospitalizations for ACS and AMI across Japan and the Tokyo area from April 2018 to March 2022. Ordinary least-squares regression was used to assess hospitalization trends before and after pSBL implementation. Seasonal adjustments were applied.</p><p><strong>Results: </strong>No significant changes were observed in ACS hospitalizations nationwide [slope difference (95 % CI): 19.97 (-16.54, 86.48)] or in the Tokyo area [2.43 (-5.10, 9.97)]. Similar findings were noted for AMI nationwide [9.18 (-38.95, 57.31)] and in Tokyo [1.48 (-3.60, 6.55)].</p><p><strong>Conclusions: </strong>The nationwide pSBL in Japan did not significantly reduce ACS or AMI hospitalizations. These findings highlight the limited effectiveness of partial smoking bans and underscore the need for more comprehensive tobacco control policies to achieve meaningful reductions in cardiovascular events.</p>","PeriodicalId":15223,"journal":{"name":"Journal of cardiology","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jjcc.2025.06.023","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Tobacco smoking is a major risk factor for acute coronary syndrome (ACS) and acute myocardial infarction (AMI). While comprehensive smoking bans reduce cardiovascular events, the effectiveness of partial smoking ban legislation (pSBL) remains uncertain. In April 2020, Japan implemented a pSBL targeting certain public facilities. This study aimed to evaluate the impact of this nationwide pSBL on ACS and AMI hospitalizations.
Methods: We conducted an interrupted time series analysis using data from the JROAD-DPC database, covering hospitalizations for ACS and AMI across Japan and the Tokyo area from April 2018 to March 2022. Ordinary least-squares regression was used to assess hospitalization trends before and after pSBL implementation. Seasonal adjustments were applied.
Results: No significant changes were observed in ACS hospitalizations nationwide [slope difference (95 % CI): 19.97 (-16.54, 86.48)] or in the Tokyo area [2.43 (-5.10, 9.97)]. Similar findings were noted for AMI nationwide [9.18 (-38.95, 57.31)] and in Tokyo [1.48 (-3.60, 6.55)].
Conclusions: The nationwide pSBL in Japan did not significantly reduce ACS or AMI hospitalizations. These findings highlight the limited effectiveness of partial smoking bans and underscore the need for more comprehensive tobacco control policies to achieve meaningful reductions in cardiovascular events.
期刊介绍:
The official journal of the Japanese College of Cardiology is an international, English language, peer-reviewed journal publishing the latest findings in cardiovascular medicine. Journal of Cardiology (JC) aims to publish the highest-quality material covering original basic and clinical research on all aspects of cardiovascular disease. Topics covered include ischemic heart disease, cardiomyopathy, valvular heart disease, vascular disease, hypertension, arrhythmia, congenital heart disease, pharmacological and non-pharmacological treatment, new diagnostic techniques, and cardiovascular imaging. JC also publishes a selection of review articles, clinical trials, short communications, and important messages and letters to the editor.